Tekla Capital Management’s Fate Therapeutics FATE Stock Holding History

Tekla Capital Management’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-31,652	Closed	-$784K	–	175
2022 Q2	$784K	Hold	31,652	–	–	0.03%	139
2022 Q1	$1.23M	Sell	31,652 -41,075	-56%	-$1.59M	0.04%	139
2021 Q4	$4.25M	Hold	72,727	–	–	0.14%	104
2021 Q3	$4.31M	Hold	72,727	–	–	0.14%	112
2021 Q2	$6.31M	Sell	72,727 -77,616	-52%	-$6.25M	0.21%	108
2021 Q1	$12.4M	Sell	150,343 -15,974	-10%	-$1.53M	0.43%	62
2020 Q4	$15.1M	Sell	166,317 -51,145	-24%	-$3.18M	0.53%	55
2020 Q3	$8.69M	Buy	217,462 +31,790	+17%	+$1.11M	0.33%	74
2020 Q2	$6.37M	Buy	185,672 +20,000	+12%	+$596K	0.24%	85
2020 Q1	$3.68M	Hold	165,672	–	–	0.17%	103
2019 Q4	$3.24M	Hold	165,672	–	–	0.12%	133
2019 Q3	$2.57M	Buy	165,672 +141,293	+580%	+$2.71M	0.11%	121
2019 Q2	$495K	Buy	+24,379	New	+$439K	0.02%	184

Other funds holding FATE

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return